Health Trials

About this trial

The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.

Eligibility criteria

Qualifiers

Age ≥ 18 years old.

Diagnosis of a Hereditary Cancer Syndrome by positive genetic testing and/or clinical criteria to undergo an endoscopy procedure (esophagoduodenoscopy and/or colonoscopy/flexible sigmoidoscopy), or endometrial screening procedure (transvaginal ultrasound and/or hysteroscopy and/or endometrial biopsy), OR

Individuals coming to Weill-Cornell Medicine/NYPH to undergo an endoscopy procedure, transvaginal ultrasound, or hysteroscopy for average-risk (population-based) recommendation OR

Individuals diagnosed with colorectal cancer or endometrial cancer coming to Weill- Cornell Medicine/NYPH for surgical treatment OR

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,120 Participants
are grouped into 6 trial groups

6

Trial groups

See each trial group below.

Locations

1
NYP/Weill Cornell Medicine10065, New YorkNew York, United States

Sponsors and collaborators

Weill Medical College of Cornell University

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov